Patrice Rioux - Jan 1, 2025 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Acting Chief Medical Officer
Signature
/s/ Karthik Radhakrishnan, Attorney-in-fact
Stock symbol
MNPR
Transactions as of
Jan 1, 2025
Transactions value $
$0
Form type
4
Date filed
1/2/2025, 06:16 PM
Previous filing
Jan 3, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +2K $0.00 2K Jan 1, 2025 Common Stock 2K $22.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock Options vesting commenced on January 1, 2025 as follows: 1/12th of 2,000 options on January 31, 2025 and each subsequent month-end thereafter.